PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
07-Mar-2024 Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge AccessWire
06-Mar-2024 San Diego-Based Mental Wellness Center Park Mental Health Integrates Clients With Community to Create a Healthy Foundation AccessWire
06-Mar-2024 Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 AccessWire
06-Mar-2024 Protagonist Therapeutics to Participate in Upcoming Investor Conferences AccessWire
06-Mar-2024 Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference AccessWire
06-Mar-2024 Ferrell Hospital and CareSimple Partner to Deliver Virtual Care to High-Need Patients in Southern Illinois AccessWire
06-Mar-2024 Intellipharmaceutics Announces Cease Trade Order AccessWire
06-Mar-2024 Phlebotomist's Actions Keep One Patient Coming Back AccessWire
06-Mar-2024 Dr. Irina Introduces the Groundbreaking Podcast 'Cures, Remedies and Beyond' AccessWire
06-Mar-2024 Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs - First Speakers Announced Henry Stewart Events
06-Mar-2024 Reveal Lasers Launches Attiva: Skin Structure Enhancement With Targeted iRF Energy AccessWire
06-Mar-2024 CLOUD DX Signs Contract with the Ottawa Hospital Research Institute (OHRI) AccessWire
06-Mar-2024 Zeto Adds New Chief Financial Officer to Accelerate Growth AccessWire
06-Mar-2024 AI-Powered Health Technology Company Bio Conscious Launches "Endobits V5" - An Industry-Leading Automated & Remote Patient Monitoring Platform To Revolutionize Diabetes Care AccessWire
06-Mar-2024 AGFA HealthCare Accelerates Growth in Enterprise Imaging Cloud Amidst Strong Market Momentum AccessWire
06-Mar-2024 Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting AccessWire
06-Mar-2024 Neptune Announces Decision of Nasdaq Hearings Panel To Delist Common Shares AccessWire
06-Mar-2024 Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma AccessWire
06-Mar-2024 Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call AccessWire
06-Mar-2024 Innoveren Scientific Announces 510(k) Submission for SkinDisc(TM) Lite AccessWire